Sansure Biotech Inc., is dedicated to the development, manufacture and distri-bution of world-class clinical diagnostic reagents, life science instruments as well as other medical products. Sanway Diagnostics Center, a sister company of Sansure, introduced an advanced management system from European and American independent labs, and is now delivering excellent services such as medical tests, molecular and pathological diagnostics nationwide. Because of out-standing progress in science and technology, Sansure has the honor to get involved in 8 national key projects such as the National "12th Five-year Plan" for preventing major infectious diseases such as AIDS and hepatitis and 13 provincial major projects.With 30,000 m2 production base constructed as per GMP, it has an annual capacity of 50 million nucleic acid tests. Cooperation has been established with Peking University, Central South University, Youan Hospital and Xiangya Hospital to establish an integrated platform to develop innovative and suitable products and enter the market quicklyOur teamUnder the leadership of PhD Dai Lizhong, the president of Sansure, PhD from Princeton University, Postdoc at MIT, professor of Central South University, Sansure has an international talent team including 1 expert of National "1000 talents plan", 5 experts of Hunan Province&＃39;s "100 talents plan", nearly 30 returned overseas talents, more than 20% staff with master and doctor degrees, and a number of international famous experts. Our honorsSansure has been awarded many national prizes such as the 2nd prize for National Science Progress; National Patent Excellent Award; National Invention and Entrepreneurship Award, etc. And over 40 invention patents have been obtained.One national and two provincial key research centers were established at Sansure: National Demonstration Center for the Application of Genetic Test Technology, Hunan Research Center for Technologies in Nucleic Acid Diagnosis, and Research Center for Technologies in Nucleic Acids-Based Diagnostics and Therapeutics (awarded by the provincial science and technology bureau).Technology and ProductsThe "magnetic bead method" and "one step method", based on fluorescence PCR technology developed by Sansure, are able to overcome key technological problems in magnetic bead binding and the manufacture of core materials for hot-start enzyme. Sansure has developed and manufactured over 100 products targeted at 8 series of detections such as hepatitis virus & AIDS, STDs, cancer-related biomarkers, respiratory tract diseases, prenatal and postnatal care, blood screening, etc, which meet the world&＃39;s standard of excellence. Based on the world-leading technology platforms, Sansure is able to provide complete PCR lab solutions with high precision and accuracy, high sensitivity and high throughput while providing easiest operation and decreasing the operation time by 70%. It&＃39;s able to meet the requirements of both large labs with a big budget to buy large machines and small labs which require more affordable testing products.For the pursuit of health, facilitating personalized treatment and improving patient care, Sansure has developed a new generation of gene sequencing platform to enable detection for tumor personalized medicine, cancer risk detection and screening for prenatal and birth defects.Wide-spreading Distribution Networks Sansure products have been widely used in over 1000 Tier A hospitals in China including 8 of the TOP 10 hospitals of specializing in treatment of infectious disease (with over 50,000 Sansure tests used per day). Sansure products are entering extensive international markets such as Germany, France, Cuba, Singapore and the rest of the world, having nearly 100 foreign distributors.